Who Just Raised

Aegle Therapeutics Corp

Woburn, MA ยท Biotechnology

Aegle Therapeutics Corp is a biotechnology company based in Woburn, Massachusetts. In a Form D filed with the SEC on August 28, 2026, it reported raising $2,277,698 from 17 investors as part of an offering of up to $2,277,698. The first sale in the offering took place on August 4, 2026.

100% of the $2.3M offering sold so far

Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of those

Website
aegletherapeutics.com
Amount raised
$2,277,698
Offering size
$2,277,698
Investors so far
17
First sale
August 4, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Woburn, Massachusetts
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $2,277,698 $2,277,698 17 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Massachusetts

Company Location Sector Raised Target Filed
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
Soterya, Inc. Boston, MA Health Care $850K $2M
Bioventrix, Inc. Mansfield, MA Health Care $1.2M $3M
Opus KSD, Inc. Pembroke, MA Health Care $681K $681K
Xact Bio, Inc. Boston, MA Health Care $10M $18M
Way Biosolutions, Inc. Cambridge, MA Health Care $2M $2M